Ipca Labs Falls 15% As US Regulator Bans Drug Import

New Delhi: Ipca Laboratories shares tanked over 15 per cent on Friday as almost all drugs manufactured by the company at its facilities at Pithampur, Silvassa and Ratlam have been banned from the US market by the country's health regulator. The stock, after making a weak opening, plummeted 14.83 per cent to Rs 437 on the Bombay Stock Exchange or BSE. On the National Stock Exchange, it dived 15.34 per cent to Rs 436.10. The US Food an...